Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
-
J Coll Physicians Surg Pak · Jul 2019
Randomized Controlled Trial Comparative StudyComparison of the Efficacy of Nilotinib and Imatinib in the Treatment of Chronic Myeloid Leukemia.
To compare the efficacy of nilotinib and imatinib in the treatment of chronic myeloid leukemia (CML). ⋯ Nilotinib is superior to imatinib in the treatment of CML. There is no significant difference in the safety of the two drugs, and the adverse reactions can be tolerated.